Key result
Higher SYNTAX score II was associated with increased long-term all-cause mortality among STEMI patients.
Why the study?
The predictive value of the SYNTAX score II for long-term outcomes in STEMI patients required comprehensive evaluation.
Does a higher SYNTAX score II predict long-term adverse outcomes in STEMI patients?
Meta-Analysis (n=7,195)
Does a higher SYNTAX score II predict long-term adverse outcomes in STEMI patients?
The SYNTAX score II is a strong predictor of long-term all-cause mortality, MACE, and heart failure in patients with STEMI.
Answers are grounded in this paper and cite their sources.
SS II aids STEMI mortality risk stratification; confirms independent prognostic value in pooled data.
PURPOSE: To assess the predictive value of SS II (SYNTAX score II) for long-term outcomes in ST-elevated myoarial infarction (STEMI) patients. Source: PubMed, EMBASE and Cochrane databases were searched up until September 24, 2021. Two investigators extracted data independently from the relevant articles. A random-effects model was conducted to combine the pooled hazard ratio (HR) or risk ratio (RR) for association between SS II and long term outcomes. Principal findings: A total of 12 articles (7,195 subjects) were included in the final meta-analyses. Analysis of nine of the articles showed that higher SS II predicted poor long term all-cause mortality among STEMI patients (pooled RRs=4.09,95%CI: 3.49-4.80). A similar association of SS II with poor long term mortality was observed when the crude HRs and adjusted HRs were pooled (crude HRs: pooled HR=1.07, 95%CI: 1.04-1.09; adjusted HRs: pooled HR=1.05, 95%CI:1.04-1.07). The STEMI patients with higher SS II also showed a higher associated with increased risk of long term major adverse cardiac events (pooled HR = 1.05, 95% CI: 1.02-1.07; pooled RR=2.28, 95%CI:2.02-2.57). A consistent association was found for heart failure among STEMI patients. Conclusion: Higher SS II predicted poor long term all-cause mortality, major adverse cardia events and heart failure among STEMI patients.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2022) conducted a meta-analysis in ST-elevated myocardial infarction (STEMI) (n=7,195). Higher SYNTAX score II vs. Lower SYNTAX score II was evaluated on long term all-cause mortality (RR 4.09, 95% CI 3.49-4.80). Higher SYNTAX score II was associated with increased long-term all-cause mortality among STEMI patients.
Synapse has enriched 10 related papers. Consider them for comparative context: